Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2020-08-31
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
In-depth Investigation of Brain Network Interactions
NCT04748146
Cortical Excitability in Post-traumatic Epilepsy
NCT05517954
Stimulation-Induced Changes in Fronto-Limbic Network
NCT05854160
Using Electroencephalography (EEG) and Transcranial Current Stimulation (tCS) to Study and Modulate Cognition Study
NCT03293316
Modulation of the Parieto-frontal Communication
NCT03434093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Arm
Repetitive Transcranial Magnetic Stimulation
Participants will receive repetitive transcranial magnetic stimulation (rTMS) to determine if stimulating areas with activating functional connectivity will activate the hypothalamus and in turn, have a measurable effect on hormone levels.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Repetitive Transcranial Magnetic Stimulation
Participants will receive repetitive transcranial magnetic stimulation (rTMS) to determine if stimulating areas with activating functional connectivity will activate the hypothalamus and in turn, have a measurable effect on hormone levels.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gender: Females and Males
* Weight: Less than 280 pounds
* Mobile
* Normal vision with corrective lenses if necessary
* Fluent in English (written and spoken)
Exclusion Criteria
* Metal implant in brains (e.g. deep stimulation), cardiac pacemaker, or cochlear implants
* Shrapnel or any ferromagnetic item in the head
* Showing symptoms of withdrawal from alcohol or benzodiazepines
* Current severe insomnia (must sleep a minimum of 4 hours the night before stimulation)
* Migraine or significant headaches
* Shoulder or neck stiffness
* Over 280 pounds
* In-dwelling ferrous metals
* Left handed
* Abnormal hearing
* Abnormal vision that cannot be corrected with lenses
* Claustrophobia
* Illicit drug use
* Psychotropic medication use
* Marijuana and/or nicotine use
* Psychiatric or neurological conditions
* Endocrine conditions
* History of head trauma with loss of consciousness
21 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Keith Sudheimer, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
53928
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.